This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, A. H. C.
Right arrow Articles by Ward, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, A. H. C.
Right arrow Articles by Ward, R. L.

 Previous Article  |  Next Article 

Journal of Virology, December 2000, p. 11574-11580, Vol. 74, No. 24
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Functional Mapping of Protective Domains and Epitopes in the Rotavirus VP6 Protein

Anthony H. C. Choi,1,* Mitali Basu,1 Monica M. McNeal,1 Jason Flint,1 John L. VanCott,1 John D. Clements,2 and Richard L. Ward1

Division of Infectious Diseases, Children's Hospital Medical Center, Cincinnati, Ohio 45229,1 and Department of Microbiology and Immunology, Tulane University Medical Center, New Orleans, Louisiana 701122

Received 8 May 2000/Accepted 25 September 2000

The purpose of this study was to determine which regions of the VP6 protein of the murine rotavirus strain EDIM are able to elicit protection against rotavirus shedding in the adult mouse model following intranasal (i.n.) immunization with fragments of VP6 and a subsequent oral EDIM challenge. In the initial experiment, the first (fragment AB), middle (BC), or last (CD) part of VP6 that was genetically fused to maltose-binding protein (MBP) and expressed in Escherichia coli was examined. Mice (BALB/c) immunized with two 9-µg doses of each of the chimeras and 10 µg of the mucosal adjuvant LT(R192G) were found to be protected against EDIM shedding (80, 92, and nearly 100% reduction, respectively; P <=  0.01) following challenge. Because CD produced almost complete protection, we prepared four E. coli-expressed, MBP-fused chimeras containing overlapping fragments of the CD region (i.e., CD1, CD2, CD3, and CD4) whose lengths ranged from 61 to 67 amino acid residues. Following i.n. immunization, CD1, CD2, and CD4 induced significant (P <=  0.004) protection (88, 84, and 92% reduction, respectively). In addition, 11 peptides (18 to 30 residues) of the CD region with between 0 and 13 overlapping amino acids were synthesized. Two 50-µg doses of each peptide with LT(R192G) were administered i.n. to BALB/c mice. Five peptides were found to elicit significant (P <=  0.02) protection. Moreover, a 14-amino-acid region within peptide 6 containing a putative CD4+ T-cell epitope was found to confer nearly complete protection, suggesting a protective role for CD4+ T cells. Mice that were protected by fragments BC and CD1 and four of the five protective synthetic peptides did not develop measurable rotavirus antibodies in serum or stool, implying that protection induced by these domains was not dependent on antibody. Together, these observations suggest that multiple regions of VP6 can stimulate protection, a region of VP6 as small as 14 amino acids containing a CD4+ T-cell epitope can stimulate nearly complete protection, and protection mediated by a subset of epitopes in the VP6 protein does not require antibodies in BALB/c mice.

* Corresponding author. Mailing address: Division of Infectious Diseases, Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229-3039. Phone: (513) 636-7679. Fax: (513) 636-7655. E-mail: anthony.choi{at}chmcc.org.

Journal of Virology, December 2000, p. 11574-11580, Vol. 74, No. 24
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Corthesy, B., Benureau, Y., Perrier, C., Fourgeux, C., Parez, N., Greenberg, H., Schwartz-Cornil, I. (2006). Rotavirus Anti-VP6 Secretory Immunoglobulin A Contributes to Protection via Intracellular Neutralization but Not via Immune Exclusion. J. Virol. 80: 10692-10699 [Abstract] [Full Text]  
  • VanCott, J. L., Prada, A. E., McNeal, M. M., Stone, S. C., Basu, M., Huffer, B. Jr., Smiley, K. L., Shao, M., Bean, J. A., Clements, J. D., Choi, A. H.-C., Ward, R. L. (2006). Mice Develop Effective but Delayed Protective Immune Responses When Immunized as Neonates either Intranasally with Nonliving VP6/LT(R192G) or Orally with Live Rhesus Rotavirus Vaccine Candidates.. J. Virol. 80: 4949-4961 [Abstract] [Full Text]  
  • Agnello, D., Herve, C. A., Lavaux, A., Darniot, M., Guillon, P., Charpilienne, A., Pothier, P. (2006). Intrarectal Immunization with Rotavirus 2/6 Virus-Like Particles Induces an Antirotavirus Immune Response Localized in the Intestinal Mucosa and Protects against Rotavirus Infection in Mice.. J. Virol. 80: 3823-3832 [Abstract] [Full Text]  
  • Jaimes, M. C., Feng, N., Greenberg, H. B. (2005). Characterization of Homologous and Heterologous Rotavirus-Specific T-Cell Responses in Infant and Adult Mice. J. Virol. 79: 4568-4579 [Abstract] [Full Text]  
  • Kramer, U., Rizos, K., Apfel, H., Autenrieth, I. B., Lattemann, C. T. (2003). Autodisplay: Development of an Efficacious System for Surface Display of Antigenic Determinants in Salmonella Vaccine Strains. Infect. Immun. 71: 1944-1952 [Abstract] [Full Text]  
  • McNeal, M. M., VanCott, J. L., Choi, A. H. C., Basu, M., Flint, J. A., Stone, S. C., Clements, J. D., Ward, R. L. (2002). CD4 T Cells Are the Only Lymphocytes Needed To Protect Mice against Rotavirus Shedding after Intranasal Immunization with a Chimeric VP6 Protein and the Adjuvant LT(R192G). J. Virol. 76: 560-568 [Abstract] [Full Text]  
  • Gerber, S., Lane, C., Brown, D. M., Lord, E., DiLorenzo, M., Clements, J. D., Rybicki, E., Williamson, A.-L., Rose, R. C. (2001). Human Papillomavirus Virus-Like Particles Are Efficient Oral Immunogens when Coadministered with Escherichia coli Heat-Labile Enterotoxin Mutant R192G or CpG DNA. J. Virol. 75: 4752-4760 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»